More than £3.4 million has been awarded by the National Institute for Health and Care Research (NIHR) to lead a landmark UK-wide clinical trial looking at whether stereotactic radiosurgery (SRS), given at the time of diagnosis, can preserve hearing in patients with vestibular schwannoma (VS).
A new landmark centre, bringing together world-leading expertise with cutting-edge research, aims to discover exactly how the human brain develops for the very first time.
Researchers at Manchester University NHS Foundation Trust and The University of Manchester continue to revolutionise the diagnosis of Perrault syndrome, with the latest discovery of a new genetic cause for the rare condition linked to hearing loss and infertility.
A 6-year-old girl is one of more than 80 people worldwide who has finally received a diagnosis of a new condition following a landmark research breakthrough supported by the NIHR Manchester Biomedical Research Centre.
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his future after he received a revolutionary stem cell gene therapy treatment developed by researchers in Manchester.
Demonstrating the impact it has made over the past year, the NIHR Manchester Biomedical Research Centre has published a summary of its key outcomes, outputs and progress.
Doctors and genetic researchers at The University of Manchester have discovered that changes in a gene leads to severe nerve damage in children following a mild bout of infection.
Two previously unknown highly frequent genetic disorders have been discovered by a study delivered through the NIHR Manchester Biomedical Research Centre, paving the way for improved diagnosis of neurodevelopmental conditions and opening new doors for future treatments.